Eli Lilly announced on Wednesday that it has initiated six lawsuits against wellness vendors. These vendors are allegedly selling unauthorized versions of its experimental weight-loss drug, retatrutide. The company aims to curb the rising tide of illegal online sales of this potent drug.
A vial of Retatrutide photographed in Brooklyn, New York, highlights the ongoing issue. According to Eli Lilly, the unauthorized distribution of retatrutide by these vendors constitutes a significant problem, prompting the legal action.
Early Detection of Atherosclerosis and Heart Disease Prevention 
Church Attendance Linked to Increased Sexual Satisfaction for Married Couples 
Dining with Loved Ones May Benefit Blood Sugar Levels 
Urgent Need for Action in East Africa’s Food Crisis 
Facing Terminal Illness: Embracing Life’s Moments 
Eating with Partners May Impact Blood Sugar Regulation